Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

13.550
-0.080-0.59%
Volume:7.18M
Turnover:96.70M
Market Cap:15.28B
PE:-52.15
High:13.690
Open:13.570
Low:13.250
Close:13.630
52wk High:35.500
52wk Low:12.310
Shares:1.13B
HK Float Shares:1.13B
Volume Ratio:0.66
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.260
ROE:-28.97%
ROA:-13.29%
PB:2.57
PE(LYR):-52.15
PS:4.43

Loading ...

Company Profile

Company Name:
ZAI LAB
Exchange:
SEHK
Establishment Date:
2013
Employees:
1869
Office Location:
Building B,899 Halei Road,Pudong,Shanghai Province,China
Zip Code:
201203
Fax:
- -
Introduction:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Directors

Name
Position
Samantha Du
Founder, Chief Executive Officer, Chairperson of the Board
John Diekman
Lead Independent Director
Leon O. Moulder, Jr.
Director
Michel Vounatsos
Director
Nisa Leung
Director
Peter Wirth
Director
Richard B. Gaynor
Director
Scott W. Morrison
Director
William Lis
Director

Shareholders

Name
Position
Samantha Du
Founder, Chief Executive Officer, Chairperson of the Board
Joshua Smiley
President and Chief Operating Officer
Yajing Chen
Chief Financial Officer
F. Ty Edmondson
Chief Legal Officer
Rafael G. Amado
President, Head of Global Research and Development